Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
16.19
+0.83 (5.40%)
Mar 10, 2026, 12:55 PM CST
22.74%
Market Cap 12.50B
Revenue (ttm) 4.00B
Net Income (ttm) 712.56M
Shares Out 813.76M
EPS (ttm) 0.86
PE Ratio 17.91
Forward PE 16.70
Dividend 0.35 (2.23%)
Ex-Dividend Date May 29, 2025
Volume 13,605,437
Average Volume 8,986,487
Open 15.35
Previous Close 15.36
Day's Range 15.35 - 16.30
52-Week Range 12.66 - 22.62
Beta -0.07
RSI 28.54
Earnings Date Apr 24, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Sector Healthcare
Founded 1990
Employees 3,869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.

Financial Statements

News

There is no news available yet.